Baseline characteristics of HSES/LSES population. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of overall population. by Krystal Hunter (6820052)

Subjects:

Diagram of study population. by Krystal Hunter (6820052)

Subjects:

A. Boxplots of the SUA showing the distribution in the Survivor group and Non-Survivor group during hospital stay. by Zhenkui Hu (11276526)

Subjects:

Baseline demographic and clinical characteristics by different SUA levels in S-AKI patients. by Zhenkui Hu (11276526)

Subjects:

Kaplan-Meier curves showing cumulative probability of all-cause mortality according to groups at 30 days (A), and 60 days (B). by Zhenkui Hu (11276526)

Subjects:

Subgroup analysis regarding the influence of different SUA levels in the hospital mortality. by Zhenkui Hu (11276526)

Subjects:

Subgroup analysis regarding the influence of different SUA levels in the ICU mortality. by Zhenkui Hu (11276526)

Subjects:

Baseline characteristics of the Survivors and Non-Survivors groups. by Zhenkui Hu (11276526)

Subjects:

Restricted cubic spline regression analysis of SUA with in hospital all-cause mortality. by Zhenkui Hu (11276526)

Subjects:

Multivariate Cox proportional hazards models for hospital mortality and ICU mortality based on the SUA level. by Zhenkui Hu (11276526)

Subjects:

Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs. by Aga E. Gelgie (17661720)

Subjects:

<i>In vitro</i> characterization of the mnuA::Tn and 0690::Tn mutants. by Aga E. Gelgie (17661720)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Anthropometric, nutritional, and variable assessments of lean mass and fat mass obtained by DXA of exclusive breastfeeding mothers (EBF), at pre-pregnancy, baseline (15 days), and... by Larissa Brazolotto Ferreira (17671168)

Subjects:

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

Subjects:

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. by Randa Mohammed Zaki (21637175)

Subjects:

Comparisons between densitometric, biochemical, and hormonal variables and bone remodeling markers of exclusive breastfeeding mothers (EBF) 15 days postpartum and the same EBF moth... by Larissa Brazolotto Ferreira (17671168)

Subjects:

Loss of mammary fitness and virulence by <i>M</i>. <i>bovis</i> 0690::Tn mutant. by Aga E. Gelgie (17661720)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects: